Literature DB >> 22306210

Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction.

Diab Mutlak1, Jonathan Lessick, Shemy Carasso, Michael Kapeliovich, Robert Dragu, Haim Hammerman, Yoram Agmon, Doron Aronson.   

Abstract

Pulmonary hypertension (PH) is usually perceived as a complication of established heart failure (HF) rather than as a predictor of HF or a marker of subclinical HF. PH may develop because of cardiac alterations that result in increased filling pressures after acute myocardial infarction (AMI). We hypothesized that PH might be a useful marker to predict the risk of HF after AMI. We studied 1,054 patients with AMI. Pulmonary artery systolic pressure (PASP) was estimated using echocardiography at the index admission and PH was defined as a PASP >35 mm Hg. The primary end point was readmission for HF at 1 year. PH was present in 471 patients (44.6%) and was strongly associated with age, decreased ejection fraction, advanced diastolic dysfunction, and moderate/severe mitral regurgitation (p <0.0001 for all comparisons). Area under the receiver operating characteristic curve was significantly higher for estimated PASP (0.74 ± 0.02) compared to other echocardiographic parameters (p = 0.02 to 0.0003). After adjustments for clinical and echocardiographic variables in a Cox model, PH was associated with a hazard ratio of 3.10 for HF (95% confidence interval 1.31 to 2.57, p <0.0001). After adding estimated PASP to a model containing clinical and echocardiographic risk factors, net reclassification improvement was 0.21 (95% confidence interval 0.11 to 0.31, p <0.0001). In conclusion, PASP integrates the severity of multiple hemodynamic determinants of increased left atrial pressures that lead to an increase in pulmonary venous pressure. In AMI, PH at the index admission is a useful marker in unmasking latent subclinical HF and predicting the development of overt HF.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22306210     DOI: 10.1016/j.amjcard.2011.12.035

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

2.  Elevated pulmonary artery systolic pressure predicts heart failure admissions in African Americans: Jackson Heart Study.

Authors:  Gaurav Choudhary; Matthew Jankowich; Wen-Chih Wu
Journal:  Circ Heart Fail       Date:  2014-06-05       Impact factor: 8.790

3.  Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.

Authors:  Jiwon Kim; Spencer Krichevsky; Lola Xie; Maria Chiara Palumbo; Sara Rodriguez-Diego; Brian Yum; Lillian Brouwer; Richard T Silver; Andrew I Schafer; Ellen K Ritchie; Maria Mia Yabut; Claudia Sosner; Evelyn M Horn; Richard B Devereux; Joseph M Scandura; Jonathan W Weinsaft
Journal:  J Am Soc Echocardiogr       Date:  2019-10-03       Impact factor: 5.251

4.  Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.

Authors:  Bradley A Maron; Bradley M Wertheim; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 30.528

5.  Epidemiology and outcomes of pulmonary hypertension in the cardiac intensive care unit.

Authors:  Jacob C Jentzer; Brandon M Wiley; Yogesh N V Reddy; Christopher Barnett; Barry A Borlaug; Michael A Solomon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-03-16

6.  Time Dependence of the Effect of Right Ventricular Dysfunction on Clinical Outcomes After Myocardial Infarction: Role of Pulmonary Hypertension.

Authors:  Keren Shahar; Wisam Darawsha; Sergey Yalonetsky; Jonathan Lessick; Michael Kapeliovich; Robert Dragu; Diab Mutlak; Shimon Reisner; Yoram Agmon; Doron Aronson
Journal:  J Am Heart Assoc       Date:  2016-07-11       Impact factor: 5.501

Review 7.  The Dark Side of the Moon: The Right Ventricle.

Authors:  Massimiliano Foschi; Michele Di Mauro; Fabrizio Tancredi; Carlo Capparuccia; Renata Petroni; Luigi Leonzio; Silvio Romano; Sabina Gallina; Maria Penco; Mario Cibelli; Antonio Calafiore
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-20

8.  Clinical implications of sleep disordered breathing in acute myocardial infarction.

Authors:  Doron Aronson; Morad Nakhleh; Tawfiq Zeidan-Shwiri; Michael Mutlak; Peretz Lavie; Lena Lavie
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

9.  Gender Differences in Risk Factors Associated With Pulmonary Artery Systolic Pressure, Heart Failure, and Mortality in Blacks: Jackson Heart Study.

Authors:  Suvasini Lakshmanan; Matthew Jankowich; Wen-Chih Wu; Chad Blackshear; Siddique Abbasi; Gaurav Choudhary
Journal:  J Am Heart Assoc       Date:  2020-01-04       Impact factor: 5.501

10.  Clinical impact of pulmonary hypertension on the outcomes of acute myocardial infarction patients with or without chronic obstructive pulmonary disease.

Authors:  Seok Oh; Ju Han Kim; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Youngkeun Ahn; Myung Ho Jeong
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.